Sorted By:


Medicamentos en Desarrollo para la Diabetes

PhRMA  |  Report

Para muchos pacientes, un diagnóstico de diabetes afecta casi todos los aspectos de, su vida, incluidas las preocupaciones de una dieta especial y otros cambios en el estilo de vida, así como los medicamentos que a diario deben tomar para manejar los niveles de glucosa en la sangre.

New report highlights more than 250 vaccines in development

PhRMA  |  Blog Post

View the full report here.

ICYMI – IMS Institute – Branded net medicine price increases “lowest in past five years”

PhRMA  |  Blog Post

Learn more at

New Medicine Approvals 2015 Report

PhRMA  |  Report

The new medicines approved by the FDA in 2015 demonstrate the tireless work of America’s biopharmaceutical researchers and scientists to deliver on the promise of science.

Study finds actual cost of 14 new medicines is billions less than predicted

PhRMA  |  Blog Post

Read more about PhRMA’s policy solutions to deliver innovative treatments to patients here.

PhRMA Board of Directors Elects New Officers, Welcomes New Member Company

PhRMA  |  Press Release

“Helping patients and addressing the burden of disease is what drives the men and women of this industry every single day,” said Bradway.

#RarePOV Conversation Generates Strong Enthusiasm for Rare Disease Day on February 28th

PhRMA  |  Blog Post

You can find information on events in other countries on the global Rare Disease Day website.

VIDEO: PhRMA CEO joins Fox Business anchor Neil Cavuto to discuss personal connection to value of innovation and White House meeting

PhRMA  |  Blog Post

Visit .com/?

Celebrating tremendous advances in HIV/AIDS on National Youth HIV/AIDS Awareness Day

PhRMA  |  Blog Post

New treatments alleviating common side effects of the disease have also become available allowing for better disease management.

World Cancer Day: Reflecting on progress and hope for the future in cancer treatment

PhRMA  |  Blog Post

Check out an interview with Marisa Dolled-Filhart, Ph.D., director of pathology and companion diagnostics at Merck, on her work as part of the oncology team.

Higher deductibles and more dissatisfaction with health plans according to new poll

PhRMA  |  Blog Post

[1] A small share (12 percent) of those surveyed is in grandfathered plans that do not have to meet new Affordable Care Act requirements.

Yep, Obamacare Costs a Fortune

Access Better Coverage  |  From Our Network

More important, and potentially worrisome for the law's defenders: Average deductibles for silver plans (the most popular type of exchange coverage) are about three times as high as on employer plans.

Examining the brain in The New Era of Medicine

PhRMA  |  Blog Post

This discussion will be live-streamed here beginning at 8:30 a.m.

New Questions About Why More Women Than Men Have Alzheimer's

From Hope To Cures  |  From Our Network

But it wasn't until after her own diagnosis a few years ago that Shives looked up the gender statistics.

A Sea Change in Treating Heart Attacks

From Hope To Cures  |  From Our Network

At Yale-New Haven Hospital, where half the patients used to have to wait at least 150 minutes before their arteries were opened, the median time is now 57 minutes.

New Report: Many Exchange Plans Burden the Most Vulnerable Patients with High Out-of-Pocket Costs for Vital Medicines; Patients left with limited access

PhRMA  |  Press Release

Eric Hargis, Colon Cancer Alliance CEO, stated, “Colorectal cancer is the second leading cause of cancer deaths in America; however, thanks to the development of personalized therapies and other innovative treatments the prognosis for colorectal cancer patients is the best it has ever been and today there are more than one million survivors in the United States.

New Study: Substantial rebates negotiated in Medicare Part D

PhRMA  |  Blog Post

This report is further evidence of the robust negotiating power of Part D plans and how they secure rebates and discounts to keep costs low for beneficiaries and taxpayers.

PhRMA Convenes Stakeholders to Discuss Value Assessments and New Ways to Pay for Medicines

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.

New Medicines Made Available through PDUFA

PhRMA  |  Graphic

The Prescription Drug User Fee Act (PDUFA) has helped bring more than 1,500 new safe and effective medications to patients.

World Anti-Counterfeiting Day Puts Spotlight On Growing Foreign Counterfeit Medicine Threat

PhRMA  |  Press Release

PhRMA members alone invested an estimated $49.5 billion in 2011 in discovering and developing new medicines.

World AIDS Day: Making progress

PhRMA  |  Blog Post

On average, it costs $2.6 billion and takes between 10 to 15 years to bring a new medicine to patients.

Welcome to the new

PhRMA  |  Blog Post

Explore PhRMA’s new digital home at

Burden on patients: Insurance benefit design’s impact on patient access to medicines

PhRMA  |  Blog Post

Asthma and COPD: Utilization management for these medicines is low compared to other conditions, but remains higher than employer coverage.

Study highlights negative impact of Canada's promise doctrine on R and D investment

PhRMA  |  Blog Post

For more information on Canada’s promise doctrine and its overall approach to IP, go to

World Cancer Day: Revolutionizing Treatment for Patients is “Not Beyond Us”

PhRMA  |  Blog Post

If you’re looking to get involved in World Cancer Day, share this post or the videos and be sure to use the hashtags #WorldCancerDay and #NotBeyondUs to help spread the world about how innovative cancer medicines are enabling people to take back their lives.

You have reviewed the first 100 results out of 2024. Each page contains 25 results. You're on page 4.

prev 1 2 3 4 5 6 next